A Population level estimate (PLE) cohort study with prior A Cohort Diagnostics study to determine the feasibility using non-identifiable data mapped to the OHDSI Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) to evaluate the risk of adverse musculoskeletal events in post-menopausal women taking AI compared to tamoxifen to treat breast cancer.